MediWound (MDWD) Retained Earnings (2013 - 2025)
MediWound (MDWD) recorded quarterly Retained Earnings of -$228.9 million in Q4 2025, down 4.49% quarter-over-quarter from -$219.1 million in Q2 2025, and down 11.65% on a YoY basis from -$259.1 million in Q4 2024.
MediWound (MDWD) Retained Earnings (2013 - 2025) Analysis & Trends
MediWound's Retained Earnings history runs 13 years deep, the most recent figure standing at -$228.9 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 11.65% year-over-year to -$228.9 million; the TTM figure through Dec 2025 stood at -$228.9 million (down 11.65% YoY), while the FY2025 annual figure was -$228.9 million, down 11.65% from the prior year.
- Retained Earnings was -$228.9 million for Q4 2025 at MediWound, down from -$219.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$137.8 million in Q1 2021 to a low of -$228.9 million in Q4 2025.
- Historically, Retained Earnings has averaged -$171.3 million across 5 years, with a median of -$164.4 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings retreated 4.0% in 2023, then slipped 17.29% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$148.5 million in 2021, then decreased by 13.2% to -$168.1 million in 2022, then fell by 4.0% to -$174.8 million in 2023, then declined by 17.29% to -$205.0 million in 2024, then decreased by 11.65% to -$228.9 million in 2025.
- The last three Retained Earnings figures came in at -$228.9 million (Q4 2025), -$219.1 million (Q2 2025), and -$205.0 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -838.07 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -228.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -228.93 Mn |
| Jun 30, 2025 | -219.09 Mn |
| Dec 31, 2024 | -205.05 Mn |
| Jun 30, 2024 | -190.86 Mn |
| Dec 31, 2023 | -174.82 Mn |
| Jun 30, 2023 | -170.88 Mn |
| Dec 31, 2022 | -168.11 Mn |
| Sep 30, 2022 | -160.65 Mn |
| Jun 30, 2022 | -156.45 Mn |
| Mar 31, 2022 | -152.10 Mn |
| Dec 31, 2021 | -148.51 Mn |
| Sep 30, 2021 | -144.35 Mn |
| Jun 30, 2021 | -141.00 Mn |
| Mar 31, 2021 | -137.81 Mn |
| Dec 31, 2020 | -134.96 Mn |
| Sep 30, 2020 | -133.22 Mn |
| Jun 30, 2020 | -131.32 Mn |
| Mar 31, 2020 | -128.22 Mn |
| Dec 31, 2019 | -125.76 Mn |
| Sep 30, 2019 | -122.32 Mn |